Patents Assigned to CARRICK THERAPEUTICS LIMITED
  • 4-[[(7-aminopyrazolo[1,5-a]pyrimidin-5-yl)amino]methyl]piperidin-3-ol compounds as CDK inhibitors
    Patent number: 11857552
    Abstract: The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain 4-[[(7-aminopyrazolo[1,5-a]pyrimidin-5-yl)amino]methyl]piperidin-3-ol compounds (referred to herein as “APPAMP compounds”) that, inter alia, inhibit (e.g., selectively inhibit) CDK (e.g., CDK1, CDK2, CDK4, CDK5, CDK6, CDK7, CDK8, CDK9, CDK10, CDK11, CDK12, CDK13, etc.).
    Type: Grant
    Filed: September 20, 2018
    Date of Patent: January 2, 2024
    Assignee: CARRICK THERAPEUTICS LIMITED
    Inventors: Ash Bahl, Ed Ainscow, Alexander Bondke, Anthony G. M. Barrett, Mihiro Sunose, Jason John Shiers, Kamaldeep Chohan